{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T16:18:54Z","timestamp":1787847534996,"version":"build-2784847793"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>The common cause of parotid fistula is parotid gland surgery and is frequently due to injury to the gland rather than to the duct. The frequency of postparotidectomy fistula is 14%. Other causes include facial trauma, congenital anomalies of the parotid gland, malignancies originating from the parotid gland and infections. Although there are several options for the treatment of parotid fistula and Frey's syndrome, very few treatment options are deemed optimal. The use of Botulinum A neurotoxin as a conservative method of treatment for parotid fistula and Frey's syndrome is a recent and evolving concept.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/njms.njms_72_20","type":"journal-article","created":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T03:08:24Z","timestamp":1615950504000},"page":"106-108","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Management of parotid fistula and Frey's syndrome with Botulinum neurotoxin type A"],"prefix":"10.4103","volume":"12","author":[{"given":"Ripon","family":"Chowdhury","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dev","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhimanyu","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20-20240908","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4103\/0975-5950.94477","article-title":"Management of parotid fistula using hypertonic saline","volume":"2","author":"Rao","year":"2011","journal-title":"Natl J Maxillofac Surg"},{"key":"R2-20-20240908","first-page":"59","article-title":"Fistulectomy of the parotid fistula secondary to suppurative parotitis: A case report","volume":"7","author":"Managutti","year":"2015","journal-title":"J Int Oral Health"},{"key":"R3-20-20240908","first-page":"92","article-title":"Le syndrome du nerf auriculo-temporal","volume":"2","author":"Frey","year":"1923","journal-title":"Rev Neurol"},{"key":"R4-20-20240908","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1172\/JCI102015","article-title":"The auriculotemporal syndrome. A clinical and pharmacologic study","volume":"27","author":"Freedberg","year":"1948","journal-title":"J Clin Invest"},{"key":"R5-20-20240908","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s10286-002-0042-x","article-title":"Mechanisms of gustatory flushing in Frey's syndrome","volume":"12","author":"Drummond","year":"2002","journal-title":"Clin Auton Res"},{"key":"R6-20-20240908","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jcms.2007.07.003","article-title":"The incidence of Frey's syndrome","volume":"36","author":"Rustemeyer","year":"2008","journal-title":"J Craniomaxillofac Surg"},{"key":"R7-20-20240908","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00106-010-2223-6","article-title":"The incidence of Frey syndrome following parotidectomy: Results of a survey and follow-up","volume":"59","author":"Neumann","year":"2011","journal-title":"HNO"},{"key":"R8-20-20240908","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.otc.2015.10.010","article-title":"Auriculotemporal Syndrome (Frey Syndrome)","volume":"49","author":"Motz","year":"2016","journal-title":"Otolaryngol Clin North Am"},{"key":"R9-20-20240908","doi-asserted-by":"crossref","first-page":"1","DOI":"10.9734\/BJMMR\/2016\/21582","article-title":"Botulinum Toxin: Dentistry Insight","volume":"12","author":"Madhok","year":"2016","journal-title":"British J Med Med Res"},{"key":"R10-20-20240908","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4103\/0019-5154.60343","article-title":"Botulinum toxin","volume":"55","author":"Nigam","year":"2010","journal-title":"Indian J Dermatol"},{"key":"R11-20-20240908","first-page":"755","article-title":"Clostridium botulinum and botulinum neurotoxin","volume":"63","author":"Hirai","year":"2011","journal-title":"Brain Nerve"},{"key":"R12-20-20240908","first-page":"734","article-title":"Botulinum toxin injection of eye muscles to correct strabismus","volume":"79","author":"Scott","year":"1981","journal-title":"Trans Am Ophthalmol Soc"},{"key":"R13-20-20240908","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1097\/00006534-200103000-00047","article-title":"Parotid gland fistula: Treatment with botulinum toxin","volume":"107","author":"Marchese-Ragona","year":"2001","journal-title":"Plast Reconstr Surg"},{"key":"R14-20-20240908","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/cam4.504","article-title":"Efficacy and safety of botulinum toxin type A for treatment of Frey's syndrome: Evidence from 22 published articles","volume":"4","author":"Xie","year":"2015","journal-title":"Cancer Med"},{"key":"R15-20-20240908","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.amjoto.2007.10.003","article-title":"Botulinum toxin therapy: A tempting tool in the management of salivary secretory disorders","volume":"29","author":"Capaccio","year":"2008","journal-title":"Am J Otolaryngol"},{"key":"R16-20-20240908","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s10006-012-0375-0","article-title":"Botulinum toxin treatment of salivary fistulas following parotidectomy: Follow-up results","volume":"17","author":"Laskawi","year":"2013","journal-title":"Oral Maxillofac Surg"},{"key":"R17-20-20240908","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.joms.2004.05.116","article-title":"Management of chronic recurrent parotitis: Current therapy","volume":"62","author":"Nahlieli","year":"2004","journal-title":"J Oral Maxillofac Surg"},{"key":"R18-20-20240908","doi-asserted-by":"crossref","first-page":"E11","DOI":"10.1002\/hed.21778","article-title":"Botulinum toxin type b for the treatment of a sialocele after parotidectomy","volume":"35","author":"Pantel","year":"2013","journal-title":"Head Neck"},{"key":"R19-20-20240908","first-page":"339","article-title":"Treatment of Frey syndrome with botulinum toxin type F","volume":"127","author":"Tugnoli","year":"2001","journal-title":"Arch Otolaryngol Head Neck Surg"}],"container-title":["National Journal of Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/njms.NJMS_72_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:21:14Z","timestamp":1787844074000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/njms.NJMS_72_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/njms.njms_72_20","relation":{},"ISSN":["0975-5950"],"issn-type":[{"value":"0975-5950","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]}}}